Sunny Reddy - Profile and Investment Details

Investor Profile

Sunny Reddy is a Venture Capital, Private Equity Firm, Investor based in New York City, New York, United States with a diverse investment portfolio that includes companies such as Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals, Asensus Surgical, Esperion Therapeutics, F2G, Garuda Therapeutics, T2 BiosystemsForge Biologics, Eidos Therapeutics, Versartis, TRIA Beauty, Nuvation Bio, Xanodyne, Seragon Pharmaceuticals, Spirox, Verona Pharma, Avrobio, Talaris Therapeutics, Bioenvision, Miramar Labs, GTx, Sirion Therapeutics, Cempra, Ambit Biosciences, CeNeRx BioPharma, BridgeBio, NextWave Pharmaceuticals, Pharmaron Holding, Topaz Pharmaceuticals Inc, Loxo Oncology, Elevation Oncology, Bridge Pharmaceuticals, Natural Dentist, Reneo Pharmaceuticals, Atreca, Aclaris Therapeutics, Promentis Pharmaceuticals, Agile Therapeutics, Biohaven Pharmaceutical, BioRelix, Cytos, Biomea Fusion, Ajax Health, Monte Rosa Therapeutics, ViewRay, Poseida Therapeutics, PowerVision, Cynapsus Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Wugen, Paratek Pharmaceuticals, Bristol-Myers Squibb, Aimmune Therapeutics, LensAR, Earlens Corporation, Arcus Biosciences, Roka Bioscience, ObsEva, Mindful Health Solutions, Aragon Pharmaceuticals, Prolacta Bioscience, . Over time, Sunny Reddy has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sunny Reddy is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Equities, Rare Diseases, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Finance, Biotechnology, Consumer Health, Medical Devices, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Gene Therapy, Digital Health, Medical, B2B, Therapeutics, Health Tech, Media and Entertainment, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Sunny Reddy, as their portfolio suggests a familiarity and interest in this area.

Understanding Sunny Reddy’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.